A federal judge overseeing the multidistrict litigation alleging anti-nausea Zofran caused birth defects has indefinitely canceled the first bellwether trial this week due to the coronavirus.

The trial, originally scheduled for May 4, comes in a case brought by the parents of Maia Rodriguez, alleging their daughter was born in 2004 with heart defects due to her mother’s use of Zofran during pregnancy. The trial would have been the first in more than 450 lawsuits filed against GlaxoSmithKline.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]